Viewing nowCombinationX-One Tablet 5/80/5 mg
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.

MFDS item code 201902300 · Approved 2019.04.15 · Insurance code 640007360
Treatment of hypertension and dyslipidemia; inhibition of atherosclerosis progression and reduction of cardiovascular disease risk
This medicine is used for patients with essential hypertension who are already taking a combination of amlodipine and valsartan but have not achieved adequate blood pressure control. Amlodipine lowers blood pressure by dilating blood vessels, while valsartan regulates blood pressure by blocking the action of substances that constrict blood vessels. Rosuvastatin is used in conjunction when dietary management is insufficient for patients with hypercholesterolemia and dyslipidemia, lowering LDL cholesterol levels to improve vascular health. Additionally, it helps delay the progression of atherosclerosis that can arise from hypercholesterolemia and reduces the risk of serious vascular diseases such as cardiovascular diseases, strokes, and myocardial infarctions. This medicine effectively improves cardiovascular health by managing both blood pressure and blood lipid levels simultaneously.
Take 1 tablet of this medicine once daily with water. It is recommended, if possible, to take it at the same time each day (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. Patients taking an amlodipine/valsartan combination and rosuvastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted before starting the amlodipine/valsartan combination; however, a direct switch to the amlodipine/valsartan combination may be considered when blood pressure is not adequately controlled with monotherapy with either component, as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients.
This medicine can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so if pregnancy is confirmed, it should be discontinued immediately. It should not be used in patients with allergies to its components or similar medications, in pregnant or breastfeeding women, or in patients with severe liver or kidney dysfunction. Caution is required for patients with lack of sodium or fluid in the body as hypotension may occur, and patients with hyperkalemia should frequently monitor their potassium levels. It should be used with caution in patients with renal vascular problems or those who have received a kidney transplant, and in patients with a history of angioedema. Patients with heart failure or post-myocardial infarction should closely monitor kidney function and heart status when administering this medicine, and patients with acute myocardial infarction should also be treated carefully. Elderly patients should start at a low dose and gradually increase the dose, and caution is advised for patients with impaired liver function. This medicine may cause muscle-related side effects such as myalgia, myopathy, and rarely rhabdomyolysis, so immediate consultation with a doctor is necessary if symptoms such as muscle pain or weakness occur. Additionally, side effects such as liver dysfunction, allergic reactions, hypotension, headache, dizziness, and edema may occur, and any unusual symptoms should be reported to healthcare providers. During the use of this medicine, interactions with other medications may occur, so it is essential to inform healthcare providers of any other medications being taken. Pregnant or breastfeeding individuals should not use this medicine, and women planning to become pregnant should use appropriate contraception methods. This medicine is not recommended for children and adolescents under 18 years of age as its safety and efficacy have not been established. In cases of overdose, symptoms such as hypotension and heart rate abnormalities may occur, so immediate medical attention is required.
Peripheral edema, heat sensation, increased ALT, increased AST, increased serum creatinine, flank pain, neck pain, dizziness, sensory loss, nasopharyngitis, rash, nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, drowsiness, orthostatic dizziness, sensory abnormality, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, erythema, hyperhidrosis, rash, itching, joint edema, low back pain, arthritis, muscle cramps, lethargy, frequency of urination, polyuria, erectile dysfunction, edema, periorbital edema, facial edema, fatigue, flushing, weakness, facial flushing, chest pain, pain, nocturia, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, hypercholesterolemia, hypoglycemia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, taste disturbance, peripheral neuropathy, hypertonic muscle syndrome, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photoallergic reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, nocturia, gynecomastia, pain, fatigue, weight loss, weight gain, decreased hemoglobin, decreased hematocrit, neutropenia, serum sickness, increased serum potassium, vasculitis, bullous dermatitis, myalgia, renal failure, kidney damage, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, thrombocytopenia, eosinophilia, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, impaired memory, forgetfulness, amnesia, memory impairment, confusion, severe muscle weakness, ocular myasthenia
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature to preserve the effectiveness of the medication and prevent degradation.
Pale pink, oval, film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Valsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharm Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.